Vivos Therapeutics, Inc. (VVOS)
0.1489
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
0.1461
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Gross Profit Margin (Quarterly) : 47.41% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 47.41% |
| March 31, 2026 | 50.67% |
| December 31, 2025 | 66.58% |
| September 30, 2025 | 52.38% |
| June 30, 2025 | 47.23% |
| March 31, 2025 | 44.16% |
| December 31, 2024 | 52.81% |
| September 30, 2024 | 56.68% |
| June 30, 2024 | 61.82% |
| March 31, 2024 | 52.38% |
| December 31, 2023 | 55.08% |
| September 30, 2023 | 52.95% |
| June 30, 2023 | 57.44% |
| March 31, 2023 | 56.05% |
| Date | Value |
|---|---|
| December 31, 2022 | 56.08% |
| September 30, 2022 | 54.66% |
| June 30, 2022 | 57.98% |
| March 31, 2022 | 65.56% |
| December 31, 2021 | 66.88% |
| September 30, 2021 | 65.78% |
| June 30, 2021 | 76.26% |
| March 31, 2021 | 72.87% |
| December 31, 2020 | 75.92% |
| September 30, 2020 | 73.02% |
| March 31, 2020 | 69.92% |
| December 31, 2019 | 65.78% |
| September 30, 2019 | 71.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Hinge Health, Inc. | 86.44% |
| Exlites Holdings International, Inc. | 0.00% |
| Xcelerate, Inc. | -- |
| Pro-Dex, Inc. | 34.75% |
| Autonomix Medical, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.07K% |
| Return on Assets | -101.7% |
| Return on Invested Capital | -204.5% |
| Profit Margin (Quarterly) | -107.2% |
| Operating Margin (Quarterly) | -93.63% |
| Return on Net Operating Assets | -114.6% |